next
gener
sequenc
ng
technolog
redefin
modu
operandi
human
microbi
genet
research
allow
unpreced
gener
larg
sequenc
dataset
short
time
scale
afford
cost
vaccin
develop
research
rapidli
take
full
advantag
advent
ng
review
provid
concis
summari
current
applic
ng
relat
research
seek
develop
vaccin
human
infecti
diseas
incorpor
studi
pathogen
host
focu
rapidli
mutat
viral
pathogen
major
target
current
vaccin
research
ng
unravel
complex
dynam
viral
evolut
host
respons
virus
thu
contribut
substanti
likelihood
success
vaccin
develop
vaccin
develop
immun
one
effect
sustain
way
prevent
infecti
diseas
also
cancer
associ
infect
vaccin
diphtheria
tetanu
poliomyel
influenza
hepat
b
measl
mump
rubella
well
pneumococc
meningococc
haemophilu
influenza
b
infect
reduc
incid
mortal
infecti
diseas
greater
howev
still
mani
medic
signific
human
infecti
diseas
vaccin
exist
key
constraint
develop
vaccin
protect
mani
preval
human
pathogen
variabl
pathogen
genom
across
epidem
even
within
singl
host
infect
episod
addit
lack
understand
microorgan
evolv
escap
host
immun
respons
convers
insuffici
insight
characterist
protect
immun
exemplifi
failur
hiv
vaccin
forefront
conundrum
infect
caus
rna
virus
common
pathogen
human
anim
larg
effect
vaccin
avail
virus
includ
highprofil
epidem
pathogen
hepat
c
viru
hcv
dengu
viru
well
endem
virus
particularli
caus
morbid
mortal
among
infant
age
individu
noroviru
enterovirus
addit
emerg
rna
viral
pathogen
major
concern
typifi
swine
flu
influenza
aros
via
genet
recombin
cross
speci
barrier
becom
pandem
sinc
develop
high
throughput
socal
ng
technolog
allow
massiv
increas
capac
sequenc
genom
rel
low
cost
short
time
frame
ng
refer
collect
highthroughput
sequenc
technolog
develop
sinc
use
amplificationbas
assay
sequenc
parallel
mani
genom
individu
templat
box
current
ng
technolog
known
second
gener
technolog
box
tabl
differenti
first
gener
sanger
sequenc
third
gener
base
singl
molecul
sequenc
review
consid
current
ng
applic
relev
vaccin
research
especi
system
biolog
see
glossari
approach
undertaken
key
element
ng
revolut
depth
mix
popul
dna
rna
genom
sequenc
ii
volum
data
iii
highthroughput
capabl
allow
rapid
direct
measur
review
glossari
chipseq
combin
chip
ng
analys
quantit
bind
site
dnaassoci
protein
across
entir
genom
haplotyp
segment
dna
rna
sequenc
carri
uniqu
allel
transmit
togeth
metagenom
analysi
sequenc
heterogen
genet
materi
recov
directli
environment
sampl
omic
refer
field
studi
biolog
end
omic
genom
proteom
metabolom
relat
suffix
ome
use
address
object
studi
field
genom
proteom
metabolom
respect
revers
vaccinolog
vaccin
research
approach
base
bioinformat
analys
pathogen
genom
predict
effici
comprehens
antigen
site
experiment
valid
rnaseq
also
known
whole
transcriptom
shotgun
sequenc
experiment
protocol
use
ng
technolog
sequenc
rna
molecul
within
biolog
sampl
effort
determin
primari
sequenc
rel
abund
rna
system
biolog
disciplin
focus
studi
system
rather
individu
biolog
compon
may
molecul
cell
organ
speci
transcriptom
term
use
defin
set
rna
molecul
produc
within
cell
popul
cell
transcriptom
disciplin
studi
rna
express
includ
long
short
rna
molecul
well
messeng
transport
rna
transcriptom
timeand
cellspecif
encompass
rna
transcript
present
cell
one
time
includ
modifi
splice
edit
degrad
form
therefor
potenti
much
complex
transcrib
portion
genom
correspond
author
luciani
f
luciani
unsweduau
box
detail
review
combin
specif
protocol
techniqu
distinguish
one
avail
technolog
anoth
templat
prepar
involv
randomli
break
dna
interest
small
fragment
attach
support
bead
suspens
solid
interfac
spatial
separ
immobil
templat
site
allow
thousand
billion
sequenc
reaction
perform
simultan
process
consist
success
incorpor
wash
scan
oper
captur
sequenc
data
second
gener
techniqu
typic
base
obtain
sequenc
clonal
amplifi
templat
wherea
third
gener
techniqu
use
singl
molecul
multipl
nucleotid
probe
addit
option
gener
technic
error
commerci
avail
ng
technolog
differ
coverag
read
length
specif
chemic
technolog
use
sequenc
read
gener
strand
tabl
instanc
roch
titanium
technolog
moder
coverag
capac
per
run
averag
read
length
nucleotid
nt
maximum
nt
contrast
illumina
solid
technolog
much
higher
coverag
gb
per
run
averag
read
length
nt
technolog
also
offer
possibl
pair
read
mechan
link
two
separ
read
across
genom
improv
qualiti
applic
ng
tabl
ii
commonli
use
ng
technolog
present
amplif
dna
materi
via
pyrosequenc
roch
ii
revers
dyetermin
sequenc
illumina
iii
sequenc
ligat
solid
field
rapidli
expand
novel
improv
platform
continu
develop
releas
exampl
includ
heliscop
helico
http
wwwhelicosbiocom
ion
torrent
life
technolog
http
wwwiontorrentcom
realtim
sequenc
platform
pacif
bioscienc
http
www
pacificbiosciencescom
third
gener
techniqu
base
sequenc
singl
molecul
dna
rna
without
intermedi
step
read
two
segment
rapidli
emerg
whole
genom
transcriptom
therefor
rather
focus
individu
detail
phenomena
without
priori
knowledg
import
ng
allow
system
approach
today
major
applic
ng
box
tabl
ii
genom
sequenc
transcriptom
analysi
rnaseq
dnaprotein
bind
analysi
chipseq
histon
modif
ngsmethyl
comprehens
review
technolog
see
vaccin
research
ng
numer
applic
figur
includ
sequenc
host
pathogen
genom
transcriptom
well
studi
divers
host
immun
respons
b
cell
analysi
ng
data
requir
complex
comput
bioinformat
techniqu
dataset
carri
import
limit
factor
notabl
limit
read
length
high
technic
error
rate
box
key
challeng
ng
technolog
bioinformat
statist
analysi
dataset
gener
ensur
high
qualiti
analys
interpret
larg
errorpron
data
set
increas
size
ng
dataset
gener
short
read
length
signific
technic
error
rate
carri
emerg
technolog
continu
demand
sophist
effici
support
system
notabl
applic
ng
analysi
studi
genom
divers
structur
significantli
hamper
current
methodolog
involv
sampl
prepar
instanc
rna
virus
process
often
involv
revers
transcript
pcr
amplif
introduc
signific
bia
term
point
mutat
recombin
event
output
sequenc
particularli
relev
rna
virus
highli
divers
popul
import
distinguish
low
frequenc
variant
technic
error
exampl
possibl
error
rate
per
base
copi
half
read
run
may
carri
least
one
error
assum
averag
read
length
bp
quantit
method
necessari
achiev
complet
understand
ng
data
instanc
analysi
may
use
inform
mathemat
model
describ
pathogen
evolut
within
host
host
still
sever
limit
applic
ng
rel
short
read
length
see
box
tabl
high
error
rate
compromis
least
part
qualiti
rang
potenti
applic
instanc
challeng
reconstruct
sequenc
haplotyp
kilobas
length
short
read
ng
data
substant
new
bioinformat
tool
develop
allow
reassembl
haplotyp
viral
genom
earli
step
alreadi
taken
achiev
goal
diploid
genom
dedic
ng
bioinformat
research
field
grow
rapidli
therebi
provid
research
commun
advanc
algorithm
access
tool
accur
data
analys
box
trend
biotechnolog
septemb
vol
ng
genom
first
breakthrough
applic
ng
vaccinolog
sequenc
full
genom
organ
host
within
hour
day
moder
cost
sinc
first
whole
human
genom
sequenc
complet
least
human
genom
complet
via
ng
avail
ongo
genom
project
similarli
larg
genom
mani
pathogen
includ
dna
virus
bacteria
parasit
sequenc
new
pathogen
identifi
via
metagenom
new
bunyaviru
sequenc
patient
unexplain
fever
thrombocytopenia
leukopenia
key
advantag
provid
ng
genom
capac
detect
lowfrequ
variant
import
element
genet
infecti
diseas
research
see
ng
studi
rapidli
mutat
virus
ng
analys
also
reveal
complex
scenario
somat
gene
rearrang
host
tissu
cell
far
common
expect
copi
number
variat
account
variat
individu
mani
recogn
singl
nucleotid
polymorph
snp
remark
exampl
comprehens
whole
genom
analysi
reveal
catastroph
event
term
chromotripsi
occur
least
human
cancer
wherebi
ten
hundr
somat
genom
rearrang
occur
mani
genom
segment
distinct
chromosom
reassembl
random
order
deriv
chromosom
avail
whole
human
genom
also
fuell
research
divers
haplotyp
within
appar
homogen
ethnic
popul
clarifi
potenti
effect
variat
within
one
gene
interplay
gene
futur
vaccin
like
incorpor
level
individu
base
genet
variabl
human
histocompat
locu
antigen
hla
regul
host
cellular
immun
restrict
antigen
present
cell
instanc
ng
use
primer
tag
individu
barcod
nucleotid
use
genotyp
hundr
individu
sever
loci
parallel
applic
ng
includ
studi
genet
variat
human
may
explain
differenti
immun
respons
pathogen
candid
vaccin
eg
via
function
polymorph
host
respons
gene
result
versatil
effici
rnaseq
box
tabl
ii
rapidli
becom
gold
standard
technolog
gather
comprehens
transcript
level
inform
rnaseq
shown
detect
transcript
microarray
util
experiment
anim
human
cell
well
obtain
transcriptom
largegenom
pathogen
exampl
four
previous
unrecogn
proteincod
region
larg
rna
splice
event
potenti
donor
acceptor
site
affect
proteincod
gene
reveal
human
cytomegaloviru
virion
product
rnaseq
also
provid
capac
studi
whether
betweensubject
differ
immun
respons
pathogen
candid
vaccin
result
alter
express
code
gene
whether
unseen
portion
genom
regul
respons
recent
ng
use
character
tempor
chang
gene
express
host
pathogen
level
infect
tabl
ng
studi
focus
noncod
rna
exampl
microrna
mirna
constitut
larg
famili
small
noncod
rna
posttranscript
regul
mrna
therebi
influenc
gene
express
program
henc
fundament
cellular
process
grow
evid
relev
human
diseas
date
mirna
identifi
includ
approxim
human
mirna
viral
infect
herpesvirus
adenovirus
viru
host
cell
mutual
crossregul
gene
express
via
mirna
see
tabl
exampl
epigenet
studi
herit
chemic
chang
occur
dna
histon
molecul
notabl
dna
methyl
histon
deacetyl
chang
affect
box
technic
review
data
analysi
approach
analysi
ng
data
gener
requir
pipelin
bioinformat
tool
serv
varieti
purpos
includ
technic
error
correct
qualiti
control
data
output
ad
hoc
analys
relev
specif
ng
applic
eg
variant
detect
transcriptom
analys
epigenet
gener
pipelin
ng
analysi
firstli
includ
qualiti
control
ng
read
manual
autom
check
qualiti
score
sequenc
read
filter
includ
elimin
end
individu
read
frequent
carri
systemat
error
qualiti
control
ng
read
align
refer
genom
avail
align
de
novo
approach
albeit
clear
consequ
term
increas
complex
analysi
time
collect
align
tool
avail
mostli
public
domain
mani
wiki
page
web
site
constantli
updat
new
exist
tool
eg
see
http
seqanswerscom
align
step
follow
specif
data
analysi
applic
consider
tool
also
avail
handl
larg
ng
data
file
allow
exchang
format
facilit
bioinformat
analys
well
exchang
inform
eg
samtool
http
samtoolssourceforgenetsamtoolsshtml
sever
recent
review
summar
current
avail
tool
sequenc
align
snp
call
transcriptom
analys
push
one
compel
limit
ng
short
read
length
new
advanc
bioinformat
tool
develop
reconstruct
long
sequenc
haplotyp
short
ng
read
approach
util
advanc
statist
bayesian
cluster
algorithm
reassembl
haplotyp
estim
frequenc
occurr
sequenc
popul
analysi
particular
relev
vaccin
develop
variant
within
pathogen
popul
may
carri
set
mutat
allow
escap
host
immun
increas
virul
recent
applic
ng
also
allow
pool
differ
genom
analysi
genet
variant
hundr
individu
singl
run
therebi
remov
key
limit
tradit
molecular
genotyp
labori
costli
assay
trend
biotechnolog
septemb
vol
gene
express
cellular
phenotyp
known
relev
mani
human
diseas
epigenet
mechan
target
host
viral
genom
henc
may
import
effect
respons
viral
vaccin
highthroughput
technolog
allow
genomescal
map
modif
adapt
dna
sequenc
detect
methyl
site
first
whole
genom
methylom
human
cell
publish
reveal
cytosin
site
methyl
major
current
challeng
delin
scope
signific
epigenet
modif
particularli
infecti
diseas
cancer
chromatin
immunoprecipit
chip
technolog
first
develop
discov
dnaprotein
bind
site
combin
ng
chipseq
appli
studi
transcript
factor
chromatinassoci
protein
polymeras
interact
dna
regul
gene
express
combin
technolog
alreadi
reveal
substanti
compon
distribut
transcript
factor
involv
develop
b
cell
respons
forese
futur
like
technolog
contribut
achiev
comprehens
understand
dnabind
profil
epigenet
modif
pattern
associ
immun
respons
pathogen
vaccin
less
centuri
vaccin
develop
use
pasteur
origin
rule
isol
inactiv
inject
microorgan
led
elimin
devast
infecti
diseas
global
major
exist
vaccin
develop
either
use
convent
mean
attenu
pathogen
serial
passag
vitro
gener
liveattenu
strain
retain
immunogen
longer
pathogen
identif
protect
antigen
use
nonliv
subunit
vaccin
latter
arduou
costli
biochem
method
tradit
use
purifi
antigen
organ
grown
cultur
result
small
number
protein
ultim
test
immunogen
limit
account
exist
evid
natur
occur
protect
antigen
sinc
end
centuri
new
technolog
propos
address
vaccin
pathogen
previou
method
fail
remark
discoveri
wholegenom
sequenc
h
influenza
allow
move
beyond
pasteur
rule
investig
pathogen
genom
inform
vaccin
design
revers
vaccinolog
rel
recent
research
disciplin
pathogen
sequenc
util
predict
antigen
protein
expos
surfac
pathogen
test
experiment
genomewid
sequenc
util
detect
potenti
antigen
site
group
b
meningococci
respons
meningococc
sepsi
mening
worldwid
bacterium
refractori
vaccin
develop
capsular
polysaccharid
polysial
acid
nonimmunogen
express
sever
human
tissu
henc
effect
selfantigen
human
immun
system
toler
revers
vaccinolog
approach
put
antigen
discov
shown
induc
antibodi
kill
bacterium
vitro
via
complementmedi
mechan
today
five
antigen
insert
prototyp
vaccin
plu
outer
membran
vesicl
compon
complet
phase
iii
clinic
trial
follow
semin
applic
mani
pathogen
current
target
revers
vaccinolog
approach
previou
technolog
fail
group
streptococcu
staphylococcu
aureu
streptococcu
pneumonia
chlamydia
pneumonia
vaccin
develop
approach
take
full
advantag
explos
highthroughput
techniqu
util
genom
transcriptom
proteom
collect
term
omic
well
comput
statist
analysi
high
throughput
data
figur
box
tabl
ng
thu
rapidli
becom
core
technolog
call
vaccinom
describ
system
biolog
approach
vaccin
research
ultim
goal
approach
delin
cellular
molecular
pathway
pathogen
induc
protect
immun
respons
recapitul
potenti
enhanc
respons
via
vaccin
util
genet
signatur
predict
immunogen
safeti
henc
efficaci
box
tabl
ii
trend
biotechnolog
septemb
vol
bacteri
pathogen
ng
applic
ng
studi
complex
pathogen
bacteria
significantli
contribut
unravel
import
element
genom
transcriptom
level
also
shed
light
pathogen
evolv
respons
clinic
intervent
exampl
ng
appli
reveal
mutat
recombin
event
permit
adapt
multidrugresist
strain
pneumonia
recombin
event
total
snp
identifi
allow
phylogenet
reconstruct
origin
distribut
strain
worldwid
similarli
applic
rnaseq
dissect
transcriptom
process
rna
helicobact
pylori
reveal
complex
scenario
discoveri
hundr
transcript
start
site
oppos
previous
known
analysi
also
reveal
previous
unknown
small
noncod
rna
probabl
involv
regul
rna
express
bacteri
growth
variat
interact
pathogen
host
determin
outcom
rang
asymptomat
infect
sever
lifethreaten
ill
effici
clearanc
establish
chronic
infect
understand
interact
key
underpin
vaccin
research
exemplifi
applic
ng
rapidli
mutat
rna
virus
review
result
lack
proofread
capac
errorpron
replicas
recombin
event
rna
virus
mutat
frequent
within
host
singl
infect
host
singl
outbreak
across
popul
time
error
rate
rna
virus
estim
misincorpor
per
nucleotid
copi
almost
millionfold
higher
error
rate
replic
human
cellular
dna
evolutionari
capac
sever
limit
strategi
design
vaccin
protect
popul
larg
spectra
variant
well
exemplifi
larg
unsuccess
vaccin
trial
hiv
nevertheless
applic
ng
studi
rna
virus
offer
uniqu
insight
rapid
adapt
dynam
within
singl
infect
host
henc
opportun
investig
short
time
scale
role
innat
adapt
immun
evolutionari
dynam
tabl
ng
offer
opportun
detail
examin
transcriptom
modif
virusinfect
host
cell
instanc
comparison
viral
host
transcriptom
hivinfect
uninfect
cell
vitro
reveal
transcript
differenti
express
peak
infect
one
transcript
viral
origin
studi
hcv
infect
rnaseq
togeth
establish
method
gene
array
proteom
provid
comprehens
descript
metabol
effect
hcv
infect
target
cell
vitro
see
also
tabl
anoth
excit
applic
ng
studi
hostpathogen
interact
combin
rna
hybrid
chipseq
recent
use
studi
transcript
network
dendrit
cell
stimul
array
pathogen
work
reveal
regulatori
function
transcript
factor
chromatin
modifi
rnabind
protein
enabl
construct
network
model
consist
coreregul
finetun
describ
pathogensens
pathway
achiev
specif
although
complex
adapt
immun
respons
crucial
protect
pathogen
repres
key
challeng
vaccin
develop
ng
recent
use
studi
cell
receptor
tcr
divers
role
rearrang
vdj
variablediversityjoin
segment
tcr
gene
shape
repertoir
antigenspecif
cell
analys
reveal
two
unexpect
result
first
vast
divers
observ
even
higher
previous
predict
second
substant
occurr
ident
tcr
sequenc
unrel
individu
instanc
complementaritydetermin
region
cdr
sequenc
share
cell
two
nonhlamatch
individu
unexpect
given
extrem
high
combinatori
rearrang
potenti
vdj
region
analys
like
salient
vaccin
develop
ng
also
appli
understand
better
divers
within
b
cell
repertoir
notabl
new
allel
variant
human
immunoglobulin
heavi
chain
variabl
region
gene
ighv
recent
identifi
analys
human
ighv
chain
rearrang
individu
hiv
studi
use
ng
structur
biolog
method
defin
detail
antibodi
neutral
approxim
strain
studi
also
show
vast
divers
neutral
antibodi
nab
direct
autolog
hiv
envelop
sequenc
across
mani
donor
includ
vaccin
recipi
infect
individu
key
advantag
ng
studi
rna
viral
infect
capac
measur
frequenc
occurr
viral
variant
within
complex
popul
ng
use
detect
variant
frequenc
low
tabl
sensit
crucial
vaccin
research
allow
detect
rare
resist
immun
escap
variant
occur
natur
infect
tabl
box
recent
investig
withinhost
evolut
hcv
earli
preseroconvers
acut
infect
two
potenti
achil
heel
identifi
viru
despit
recognit
hundredsthousand
viral
variant
present
inoculum
transmiss
event
involv
share
inject
drug
use
apparatu
founder
gener
establish
infect
recipi
ii
despit
rapid
mark
increas
viral
divers
variant
subsequ
develop
earli
infect
second
promin
decreas
divers
observ
within
day
associ
adapt
immun
respons
target
viru
figur
sequenti
genet
bottleneck
review
trend
biotechnolog
septemb
vol
event
indic
potenti
vaccin
strategi
target
founder
virus
hiv
shown
founder
virus
phenotyp
signatur
may
relev
vaccin
strategi
includ
preferenti
chemokin
receptor
usag
effici
replic
cell
ng
also
appli
studi
divers
influenza
epidem
exampl
immunosuppress
patient
treat
neuraminidas
inhibitor
carri
mix
infect
three
genet
distinct
variant
well
drugresist
mutat
least
viral
popul
impact
noroviru
transmiss
event
viral
divers
contribut
divers
intrahost
evolut
typic
short
time
period
shed
normal
host
day
prolong
period
day
recent
investig
immunocomprom
individu
minor
variant
frequenc
low
success
transmit
indic
transmiss
import
sourc
noroviru
diversif
interhost
level
ng
detect
immun
escap
pathogen
genom
sequenc
via
ng
larg
remov
previou
gap
vaccin
develop
possibl
sequenc
full
genom
rna
viru
within
day
avail
genom
combin
bioinformat
predict
epitop
see
review
allow
effici
screen
pathogen
genom
experiment
confirm
immunogen
common
applic
ng
quantif
escap
variant
frequenc
occurr
unpreced
depth
accuraci
infect
initi
one
founder
variant
design
f
blue
line
replac
sequenti
two
relat
variant
respect
red
unbroken
broken
line
graph
set
amino
acid
sequenc
indic
distinguish
residu
differ
variant
sequenc
also
show
locat
put
cytotox
cell
ctl
epitop
pink
shade
antibodi
epitop
green
shade
well
mutat
associ
reduct
viral
reproduct
vitro
experi
light
blue
shade
figur
adapt
context
liveattenu
simian
immunodefici
viru
vaccin
administ
macaqu
ng
use
studi
kinet
occurr
escap
variant
parallel
evolut
tcr
bchain
repertoir
specif
wildtyp
epitop
mamua
restrict
tat
interest
applic
ng
hostpathogen
evolut
escap
variant
occur
frequenc
low
first
week
postvaccin
variant
decay
rapidli
frequenc
first
week
postvaccin
despit
diversif
avail
cell
repertoir
time
cell
respons
remain
rel
focus
wild
type
tat
epitop
vaccin
design
ng
offer
potenti
improv
current
revers
vaccinolog
strategi
polyval
mosaic
hiv
vaccin
develop
silico
algorithm
use
select
viral
protein
best
encompass
natur
occur
strain
vaccin
gener
broad
crossreact
respons
common
epitop
see
review
revers
vaccinolog
strategi
therefor
offer
potenti
broad
global
applic
ng
also
provid
effici
tool
surveil
ongo
evolut
import
pathogen
exemplifi
influenza
infect
new
vaccin
design
annual
account
continu
viral
divers
drift
well
screen
major
chang
shift
incid
strain
potenti
associ
pandem
new
influenza
vaccin
design
therefor
necessit
prompt
decis
rapid
implement
vaccin
manufactur
field
applic
contain
new
pandem
threat
vaccin
safeti
ng
also
import
applic
vaccin
safeti
ngsbase
approach
use
detect
virul
mutat
vaccin
batch
instanc
detect
neurovirul
variant
polioviru
genom
liveattenu
polio
vaccin
contrast
standard
approach
pcr
restrict
fragment
length
polymorph
pcrrflp
screen
less
sensit
limit
detect
recogn
mutat
similarli
use
eight
liveattenu
viral
vaccin
trival
oral
polioviru
rubella
measl
yellow
fever
varicellazost
multival
measl
mumpsrubella
two
rotaviru
vaccin
ng
analys
reveal
minor
unknown
variant
well
sequenc
virus
produc
avian
primat
tissu
cultur
cell
year
come
ng
new
third
gener
singl
cell
singl
molecul
sequenc
becom
gold
standard
molecular
technolog
immunolog
virolog
vaccinolog
howev
least
three
key
issu
resolut
widescal
applic
ng
vaccin
research
first
qualiti
ng
data
must
improv
resolut
technic
error
see
box
may
extend
current
spectrum
ng
applic
detect
complex
genet
rearrang
insert
delet
recombin
event
rapidli
mutat
pathogen
genom
second
era
vaccin
research
increasingli
acquir
system
biolog
approach
ng
combin
larg
scale
highthroughput
technolog
studi
proteom
mass
spectrometri
flow
cytometri
combin
mass
cytometri
allow
simultan
measur
paramet
singl
cell
provid
simultan
rapid
low
cost
flow
integr
inform
genom
transcriptom
proteom
host
pathogen
scenario
comput
analys
need
integr
workflow
simpli
analysi
data
rather
integr
compon
studi
design
final
futur
develop
ng
bring
forward
new
challeng
instanc
singl
molecul
third
gener
sequenc
probabl
remov
constraint
short
read
introduc
obstacl
new
technic
error
challeng
experiment
design
major
target
vaccinolog
therapeut
prevent
vaccin
emerg
rapidli
mutat
pathogen
hiv
hcv
well
complex
bacteri
pathogen
mycobacterium
tuberculosi
context
current
focu
understand
better
hostpathogen
interact
integr
ng
novel
technolog
describ
elucid
detail
understand
aspect
virushost
interact
guid
vaccin
develop
